Neonatal monosodium glutamate administration increases aminooxyacetic acid (AOA) susceptibility effects in adult mice

Proceedings of the Western Pharmacology Society

Volumn 52, Issue , 2009, Pages 72-74

  Campos Sepúlveda, Alfonso Efraín ^a   Enríquez, Maria Elena Martínez ^a   Arellanes, Raúl Rodríguez ^a   Peláez, Luz Elena ^a   Amézquita, Alyn Lizeth Rodríguez ^a   Razo, Alyne Cadena ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AMINOOXYACETIC ACID; GLUTAMATE SODIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIRTH; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HYPNOSIS; HYPOTHERMIA; LETHALITY; MALE; MOUSE; MOUSE STRAIN; NERVE CELL EXCITABILITY; NEWBORN; NEWBORN PERIOD; NONHUMAN; RECEPTOR UPREGULATION;

AMINOOXYACETIC ACID; ANIMALS; ANIMALS, NEWBORN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GABA AGENTS; MALE; MICE; NEURONS; SODIUM GLUTAMATE;

EID: 77951593681     PISSN: 00838969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Curtis, D.R. and Watkins, J.C. (1960) J. Neurochem. 6, 117.
2. Collingridge, G.Ll and Lester, R.A.J.(1989) Pharmacol. Rev. 41, 143.
3. Nicoletti, F., Bruno, V., Copani, V.A., Casabona. G. and Knopfel,T. (1996) TINS 19, 267.
4. Bliss, T.V.P. and Collingridge, G.L. (1993) Nature 361, 31.
5. Staubli, U., Rogers, G. and Lynch, G. (1994) Proc. Natl. Acad. Sci. 91, 777.
6. McGaugh, J.L. and Izquierdo, I. (2000) TIPS 21, 208.
7. Collingridge, G.L. and Singer, W. (1990) TIPS 11, 290.
8. Bortolotto, Z.A. and Collingridge, G.L. (1993) Neuropharmacol. 32, 1.
9. Arai, A. and Lynch, G. (1992) Brain. Res. 598, 173.
10. Bashir, Z.I., Bortolotto, Z.A., Davies. C.H. et. al. (1993) Nature 363, 347.
11. Lucas, D.R. and Newhouse, J.P. (1957) AMA Arch. Ophthalmol. 58, 193.
12. Olney, J.W. (1969) Science 164, 717.
13. Kizer, J.S., Nemeroff, C.H.B. and Youngblood, W.W. (1978) Pharmacol. Rev. 29, 301.
14. Meister, B., Ceccatelli, S., Hokfelt., T., Anden, N.E., Andén, M. and Theodorsson, E. (1989)Exp. Brain. Res. 76, 343.
15. Meister, B. (1991) Methods in Neurosciences. USA, Acad Press.
16. Chambille, I. and Serviere, J. (1993) J. Comp. Neurol. 338, 67.
17. Olney, J.W: (1989) Biol. Psychiat. 26, 505.
18. Mody, I. and McDonald, J.F. (1995) TIPS 16, 356.
19. Danysz, W., Parsons, C.G., Bresink, I. and Quack, G. (1995) Drug News Perspect. 8, 261.
20. Schoepp, D.D. and Conn, P.J. (1993) TIPS 14, 13.
21. Wisden, W. and Seeburg, P.H. (1993) Curr. Opin. Neurobiol. 3, 291.
22. Dingledine, R., Borges, K., Bowie, D. and Traynelis, S. (1999) Pharmacol. Rev. 51, 8.
23. th ed.
24. Qume, M., and Fowler, L.J. (1996) Biochem. Pharmacol. 52, 1355.
25. Zheng-Xiong, X.I., and Elliot, A.S. (2000) J.Pharmacol. Exp. Ther. 294, 613.
26. Suzdak, P.D., Schwartz, R.D., Skolnick, P. and Paul, S.M. (1986) Proc. Natl. Acad. Sci. USA 83, 4071.
27. Beas ZC, Sanchez RMY, Ureña GME & Feria VA: Neurochem Internac 33: 217 (1998).
28. Jennes L, Stump WE, Bissette G, Nemeroff CB: Brain Res 308: 245 (1984).
29. Di Giorgio, R.M., De Luca, G.C., Garofalo, M.P., Conti, C. and Lentile, R. (1985) Italian J. Biochem. 34, 19.